Alex Ignatius Costa

Alex Ignatius Costa currently serves as a Senior Director, Business Management/GEN AI at GN Group, where leadership is provided for the strategic initiative GN BrainWorks, focusing on the intersection of hearing and brain health. With a strong background in health innovation, Costa has previously held roles such as Advisor and Member of the Funding Board at the Massachusetts Institute of Technology and New Product Planning Lead at LEO Pharma, where responsibilities included managing drug development projects and driving innovation through partnerships. Educational qualifications encompass a Master's in Business Administration with a focus on Bioentrepreneurship and a Master of Science in Medical Technology, complemented by executive education in venture capital and marketing management. Costa's experience also includes co-founding the Hacking Dermatology initiative, fostering community and innovation within the dermatology sector.